Capital World Investors
TECH icon

Capital World Investors’s Bio-Techne TECH Stock Holding History

Capital World Investors’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$37.9M Buy
536,962
+227,199
+73% +$12.3M ﹤0.01% 506
2026
Q1 		$16.2M Buy
+309,763
New +$18.6M ﹤0.01% 545
2023
Q4 		– Sell
-272,339
Closed -$18.5M – 531
2023
Q3 		$18.5M Hold
272,339
– – ﹤0.01% 444
2023
Q2 		$22.2M Sell
272,339
-85,500
-24% -$6.87M ﹤0.01% 430
2023
Q1 		$26.5M Buy
+357,839
New +$27.6M 0.01% 420

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Capital World Investors's TECH Position: Q2 2026 in Review

Capital World Investors increased its Bio-Techne (TECH) stake by 73% in Q2 2026, buying an estimated $12.3M and bringing the position to 536,962 shares worth $37.9M. The position accounts for ﹤0.01% of the portfolio, ranked #506.

Capital World Investors first reported a position in TECH in Q1 2023 and has held it in 5 quarters since. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Capital World Investors held 536,962 shares of Bio-Techne worth $37.9M as of Q2 2026.
  • Capital World Investors bought 227,199 Bio-Techne shares in Q2 2026, an estimated $12.3M.
  • Bio-Techne made up ﹤0.01% of Capital World Investors's portfolio in Q2 2026, its #506 holding.
  • Capital World Investors first reported a position in Bio-Techne in Q1 2023 and has held it in 5 quarters since.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Capital World Investors's 13F filing for Q2 2026, filed 12 Aug 2026.